ITM And Grand Pharma Enter Into A Commercialization Agreement For Targeted Radiopharmaceuticals In…
Grand Pharma has licensed the development, manufacturing and commercialization rights of ITM’s Targeted Radionuclide Therapeutic candidates ITM-11…